TSUB.F Stock Overview
Engages in the research and development of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, and presbyopia.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Tsubota Laboratory Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥4.35 |
| 52 Week High | JP¥4.35 |
| 52 Week Low | JP¥4.35 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0% |
Recent News & Updates
Recent updates
Shareholder Returns
| TSUB.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 0.2% | 0.4% |
| 1Y | n/a | 17.1% | 22.9% |
Return vs Industry: Insufficient data to determine how TSUB.F performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how TSUB.F performed against the US Market.
Price Volatility
| TSUB.F volatility | |
|---|---|
| TSUB.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: TSUB.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine TSUB.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 10 | Kazuo Tsubota | www.tsubota-lab.com |
Tsubota Laboratory Incorporated engages in the research and development of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, and presbyopia. The company was incorporated in 2012 and is based in Tokyo, Japan.
Tsubota Laboratory Incorporated Fundamentals Summary
| TSUB.F fundamental statistics | |
|---|---|
| Market cap | US$81.46m |
| Earnings (TTM) | US$160.53k |
| Revenue (TTM) | US$5.02m |
507.5x
P/E Ratio16.2x
P/S RatioIs TSUB.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TSUB.F income statement (TTM) | |
|---|---|
| Revenue | JP¥750.00m |
| Cost of Revenue | JP¥87.00m |
| Gross Profit | JP¥663.00m |
| Other Expenses | JP¥639.00m |
| Earnings | JP¥24.00m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Nov 10, 2023
| Earnings per share (EPS) | 0.94 |
| Gross Margin | 88.40% |
| Net Profit Margin | 3.20% |
| Debt/Equity Ratio | 7.2% |
How did TSUB.F perform over the long term?
See historical performance and comparison